Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OxyChem is the commonly used name for Occidental Chemical Corporation, a large industrial chemical manufacturer rather than a life sciences, biotech, pharma, or healthcare company. The business produces commodity and specialty chemicals including chlor-alkali products, vinyls/PVC, chlorinated organics, and calcium chloride for industrial end markets. Its products support downstream applications that can include pharmaceuticals and healthcare manufacturing, but OxyChem itself is not a therapeutic developer and does not operate a biotech-style clinical pipeline. Historically it was Occidental Petroleum's chemical business, and it was acquired by Berkshire Hathaway in January 2026 for approximately $9.7 billion. For the requested name "Oxykem," the closest clear company match appears to be OxyChem, but this is not an exact name match.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oxykem.